Sorafenib in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

Clinical trial NCT00278382 · COMPLETED

Trial details

NCT number: NCT00278382
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anaplastic Large Cell Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Mantle Cell Lymphoma

Start date: 2005-10-01
Primary completion: 2007-12-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.